I shopped for a number of sold out biotechs in December and picked and chose a number of sold out biotechs.
IOBT --I missed. But there are legs here. I have done well on four of my picks. Still waiting on two.
Time will tell.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent IOBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:44:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:18:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:14:19 PM
- IO Biotech to Present at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:30:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:13:53 PM
- IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 05/14/2024 11:55:00 AM
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:30:00 PM
- IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103 • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
- IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/05/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 08:56:44 PM
- IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/06/2024 09:11:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:46:56 PM
- IO Biotech Announces 2023 Fourth-Quarter and Year-End Results • GlobeNewswire Inc. • 03/05/2024 09:40:01 PM
- IO Biotech to Present at 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:11:55 PM
- IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial • GlobeNewswire Inc. • 12/21/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 10:37:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:37 PM
- IO Biotech Announces 2023 Third Quarter Results • GlobeNewswire Inc. • 11/13/2023 01:12:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:10:53 PM
- IO Biotech Appoints Helen Collins, MD, to its Board of Directors • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM